Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    XOMA Corporation (XOMAO)

    Price:

    25.39 USD

    ( - -0.18 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    XOMAO
    Name
    XOMA Corporation
    Industry
    Biotechnology
    Sector
    Healthcare
    Price
    25.390
    Market Cap
    306.907M
    Enterprise value
    325.046M
    Currency
    USD
    Ceo
    Owen P. Hughes Jr.
    Full Time Employees
    13
    Website
    Ipo Date
    2021-04-12
    City
    EmeryVille
    Address
    2200 Powell Street

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Royalty Pharma plc

    VALUE SCORE:

    7

    Symbol
    RPRX
    Market Cap
    15.701B
    Industry
    Biotechnology
    Sector
    Healthcare

    2nd position

    Genmab A/S

    VALUE SCORE:

    11

    Symbol
    GMAB
    Market Cap
    99.056B
    Industry
    Biotechnology
    Sector
    Healthcare

    The best

    Agios Pharmaceuticals, Inc.

    VALUE SCORE:

    12

    Symbol
    AGIO
    Market Cap
    2.254B
    Industry
    Biotechnology
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -42.540
    P/S
    10.539
    P/B
    5.669
    Debt/Equity
    1.582
    EV/FCF
    -47.801
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    11.564
    Earnings yield
    -0.024
    Debt/assets
    0.513
    FUNDAMENTALS
    Net debt/ebidta
    -4.498
    Interest coverage
    -67.179
    Research And Developement To Revenue
    0.079
    Intangile to total assets
    0.203
    Capex to operating cash flow
    -0.000
    Capex to revenue
    0.000
    Capex to depreciation
    0.004
    Return on tangible assets
    -0.054
    Debt to market cap
    0.282
    Piotroski Score
    4.000
    FUNDAMENTALS
    PEG
    0.772
    P/CF
    -44.013
    P/FCF
    -43.566
    RoA %
    -4.320
    RoIC %
    -3.640
    Gross Profit Margin %
    96.892
    Quick Ratio
    4.881
    Current Ratio
    4.881
    Net Profit Margin %
    -25.021
    Net-Net
    -4.546
    FUNDAMENTALS PER SHARE
    FCF per share
    -0.777
    Revenue per share
    3.213
    Net income per share
    -0.804
    Operating cash flow per share
    -0.777
    Free cash flow per share
    -0.777
    Cash per share
    6.251
    Book value per share
    7.700
    Tangible book value per share
    3.916
    Shareholders equity per share
    6.033
    Interest debt per share
    9.558
    TECHNICAL
    52 weeks high
    25.870
    52 weeks low
    23.320
    Current trading session High
    25.465
    Current trading session Low
    25.310
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    -42.5%
    Years of div. Increase
    3.000
    Years of div.
    5.000
    Q-shift
    1.000
    Dividend per share
    0
    SIMILAR COMPANIES
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Pharmaceuticals
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -140.715
    logo

    Country
    US
    Sector
    Real Estate
    Industry
    REIT - Mortgage
    Dividend yield
    0.11204482%
    Payout Ratio
    146.34578%
    P/E
    10.375
    logo

    Country
    US
    Sector
    Real Estate
    Industry
    REIT - Mortgage
    Dividend yield
    0.18548387%
    Payout Ratio
    -34.082562%
    P/E
    -1.514
    logo

    Country
    BM
    Sector
    Financial Services
    Industry
    Insurance - Reinsurance
    Dividend yield
    0%
    Payout Ratio
    9.428403000000001%
    P/E
    17.783
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0.083302684%
    Payout Ratio
    -56.687039999999996%
    P/E
    -32.197
    DESCRIPTION

    XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

    NEWS